TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27785682

Group type: EXPERIMENTAL
Intervention: PM group (learned at 8 pm, tested at 8 am after sleep)
Number of subjects: 56

Group type: COMPARATOR
Intervention: AM group (learned at 8 am, tested at 8 pm without sleep)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Both groups (AM and PM) after 24 hours
Number of subjects: 56
Study: 26222533

Group type: EXPERIMENTAL
Intervention: Buffered Tc-sulfur colloid (pH 7.40)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard-of-care Tc-sulfur colloid
Number of subjects: 60
Study: 24314887

Group type: EXPERIMENTAL
Intervention: Sertraline treatment
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Remission of depression at week 12
Number of subjects: 131

Group type: COMPARATOR
Intervention: Nonremission of depression at week 12
Number of subjects: 131
Study: 23040570

Group type: EXPERIMENTAL
Intervention: Colchicine 0.5 mg twice daily for 3 months
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Colchicine 0.5 mg twice daily
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 161
Study: 20020412

Group type: EXPERIMENTAL
Intervention: CondECC
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: ECC
Number of subjects: 75

Group type: COMPARATOR
Intervention: CONT
Number of subjects: 75
Study: 17447216

Group type: EXPERIMENTAL
Intervention: SonoVue
Number of subjects: 65

Group type: COMPARATOR
Intervention: Levovist
Number of subjects: 65
Study: 15053242

Group type: EXPERIMENTAL
Intervention: 1 microg ACTH stimulation test
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Metyrapone test (30 mg/kg orally at 23:00 h)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Adrenal size comparison
Number of subjects: 22
Study: 15842577

Group type: EXPERIMENTAL
Intervention: Valdecoxib (10 and 20 mg once daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Naproxen (500 mg twice daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diclofenac (75 mg twice daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ibuprofen (800 mg three times daily)
Number of subjects: 0
Study: 10561336

Group type: EXPERIMENTAL
Intervention: Tamoxifen 10 mg on alternate days
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Tamoxifen 10 mg/d
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg/d
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 10999061

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HOT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional therapy only
Number of subjects: 60
Study: 2060122

Group type: EXPERIMENTAL
Intervention: Coronary artery disease patients during stress tests
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Syndrome X patients during stress tests
Number of subjects: 23
Study: 6362245

Group type: EXPERIMENTAL
Intervention: 20 mg nifedipine (N)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 20 mg isosorbiddinitrate (I)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Combination of 20 mg isosorbiddinitrate and 20 mg nifedipine (I + N)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 36
Study: 31727687

Group type: EXPERIMENTAL
Intervention: Biochemical markers (up to 16 biomarkers) added to routinely measured clinical risk factors
Number of subjects: 7482

Group type: EXPERIMENTAL
Intervention: Biochemical markers (15 biomarkers)
Number of subjects: 7482

Group type: EXPERIMENTAL
Intervention: Biochemical markers (12 biomarkers + 1 additional)
Number of subjects: 7482

Group type: EXPERIMENTAL
Intervention: Every 0.1 mL/min/1.73 m2 predicted annual fall in eGFR
Number of subjects: 7482
Study: 30725411

Group type: COMPARATOR
Intervention: Methionine-restricted total parenteral nutrition (MR TPN) with chemotherapy-containing amino acid solution (AO-90)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 1-day methionine-restricted diet combined with cystemustine (60 mg/m2 every 2 weeks)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Commercially available methionine-restricted medical food
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Dietary methionine restriction combined with FOLFOX regimen
Number of subjects: 34
Study: 27707530

Group type: EXPERIMENTAL
Intervention: Aripiprazole lauroxil (AL) 441mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aripiprazole lauroxil (AL) 882mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26875002

Group type: EXPERIMENTAL
Intervention: Latanoprostene bunod 0.024% qpm
Number of subjects: 420

Group type: COMPARATOR
Intervention: Timolol maleate 0.5% BID
Number of subjects: 420
Study: 23802645

Group type: EXPERIMENTAL
Intervention: Self-etch (SE)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Etch-and-rinse + moist dentin (ERm)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Etch-and-rinse + dry dentin (ERd)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Selective enamel etching (Set)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Overall retention
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Marginal adaptation
Number of subjects: 39
Study: 22889317

Group type: EXPERIMENTAL
Intervention: Coronary flow reserve (CFR)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Insulin sensitivity
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Arterial stiffness
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Endothelial function
Number of subjects: 39
Study: 19319508

Group type: EXPERIMENTAL
Intervention: Acamprosate
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 17887929

Group type: EXPERIMENTAL
Intervention: Fine-needle aspiration (FNA) of parathyroid adenomas
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (non-FNA)
Number of subjects: 30
Study: 15679129

Group type: EXPERIMENTAL
Intervention: Transnasal butorphanol 2 mg
Number of subjects: 56

Group type: COMPARATOR
Intervention: Transnasal placebo
Number of subjects: 56
Study: 12622925

Group type: EXPERIMENTAL
Intervention: Percutaneous gel 17beta‐estradiol (E(2)) 1.5 mg/d plus micronized progesterone (MP) 100 mg/d
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Percutaneous gel 17beta‐estradiol (E(2)) 1.5 mg/d plus medroxyprogesterone acetate (MPA) 2 mg/d
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Percutaneous gel 17beta‐estradiol (E(2)) 0.75 mg/d plus micronized progesterone (MP) 100 mg/d
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Percutaneous gel 17beta‐estradiol (E(2)) 0.75 mg/d plus medroxyprogesterone acetate (MPA) 2 mg/d
Number of subjects: 60

Group type: COMPARATOR
Intervention: All groups (combined)
Number of subjects: 60
Study: 9664755

Group type: EXPERIMENTAL
Intervention: Salicin with photoprotective mask
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo with photoprotective mask
Number of subjects: 54
Study: 7851681

Group type: EXPERIMENTAL
Intervention: Chronic euglycaemic hyperinsulinaemia (+72 pmol/l) for 72-96 hours
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Chronic hyperglycaemic hyperinsulinaemia (+78 pmol/l) for 72 hours
Number of subjects: 15
Study: 30120832

Group type: EXPERIMENTAL
Intervention: Serratus anterior plane block with 30 ml ropivacaine 0.375%
Number of subjects: 89

Group type: COMPARATOR
Intervention: No block (control)
Number of subjects: 89
Study: 28477992

Group type: EXPERIMENTAL
Intervention: iNPWT (intervention negative pressure wound therapy)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Standard postoperative (dry gauze) dressing (control)
Number of subjects: 71
Study: 26597808

Group type: EXPERIMENTAL
Intervention: Caring for Couples Coping with Cancer '4Cs' Programme
Number of subjects: 0
Study: 23143093

Group type: EXPERIMENTAL
Intervention: Postural education program (6 sessions over 6 weeks)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Usual school curriculum
Number of subjects: 137
Study: 21974699

Group type: COMPARATOR
Intervention: Bicarbonate hemodialysis (BHD)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Acetate-free citrate hemodialysis (AFHD)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Re-bicarbonate hemodialysis (ReBHD)
Number of subjects: 44
Study: 19902462

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 16823554

Group type: COMPARATOR
Intervention: SureFil (S)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Alert (A)
Number of subjects: 33
Study: 12480080

Group type: EXPERIMENTAL
Intervention: Rivastigmine treatment
Number of subjects: 0
Study: 11080707

Group type: EXPERIMENTAL
Intervention: Pediatric asthma caregiver diary scale
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Day without asthma symptoms (DWAS)
Number of subjects: 125
Study: 9709276

Group type: EXPERIMENTAL
Intervention: Mammographic screening every 18 months
Number of subjects: 25941

Group type: COMPARATOR
Intervention: Control group (not invited to screening until the fifth screen)
Number of subjects: 25941
Study: 8346826

Group type: EXPERIMENTAL
Intervention: Continuous spinal anesthesia (CSA) with 0.5% bupivacaine, initial dose 1 mL, reinjection 1 mL
Number of subjects: 77

Group type: COMPARATOR
Intervention: Continuous epidural anesthesia (CEA) with 0.5% bupivacaine, initial dose 10 mL, reinjection 5 mL
Number of subjects: 77

Group type: COMPARATOR
Intervention: Single-dose spinal anesthesia (SSA) with 0.5% bupivacaine, initial dose 3 mL
Number of subjects: 77
Study: 3721944

Group type: EXPERIMENTAL
Intervention: Phenobarbital
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 30285755

Group type: EXPERIMENTAL
Intervention: 4-month dietary intervention delivered by promotoras via home visits and telephone calls
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: 4-month dietary intervention
Number of subjects: 361

Group type: COMPARATOR
Intervention: Delayed treatment control group
Number of subjects: 361
Study: 27283862

Group type: EXPERIMENTAL
Intervention: Low-dose CT screening
Number of subjects: 15822
Study: 24837481

Group type: EXPERIMENTAL
Intervention: Enhanced contact with interventionist (EC)
Number of subjects: 1838

Group type: EXPERIMENTAL
Intervention: Enhanced contact with interventionist + skills (EC + skills)
Number of subjects: 1838

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 1838
Study: 22330753

Group type: EXPERIMENTAL
Intervention: 6g FPP®/day for 14 weeks
Number of subjects: 0
Study: 20701016

Group type: EXPERIMENTAL
Intervention: CKD screening tests (e.g., glomerular filtration rate)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CKD screening
Number of subjects: 0
Study: 19146124

Group type: EXPERIMENTAL
Intervention: Colgate 3600 Deep Clean (AFT version)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Colgate 3600 Deep Clean (stapled version)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Oral B Indicator
Number of subjects: 109
Study: 15990003

Group type: EXPERIMENTAL
Intervention: LCAF (Late course accelerated hyperfractionated radiotherapy)
Number of subjects: 111

Group type: COMPARATOR
Intervention: LCAF+CT (Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy)
Number of subjects: 111
Study: 19753739

Group type: EXPERIMENTAL
Intervention: 400 mg/day itraconazole for 3 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 400 mg/day itraconazole for 1 day
Number of subjects: 60

Group type: COMPARATOR
Intervention: 200 mg/day itraconazole for 5 days
Number of subjects: 60
Study: 10726429

Group type: EXPERIMENTAL
Intervention: Short rest interval (40 sec)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Long rest interval (160 sec)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 14
Study: 8749210

Group type: EXPERIMENTAL
Intervention: Dressed wounds
Number of subjects: 68

Group type: COMPARATOR
Intervention: Exposed wounds
Number of subjects: 68
Study: 2028586

Group type: EXPERIMENTAL
Intervention: Dexamethasone, 4 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Acetazolamide, 250 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 7032341

Group type: EXPERIMENTAL
Intervention: Hyposensitization treatment
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 31280790

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral group therapy (CBGT) + 4 resilience and coping strategy sessions (total 16 sessions)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cognitive behavioral group therapy (CBGT)
Number of subjects: 100
Study: 29441577

Group type: EXPERIMENTAL
Intervention: CHARM intervention
Number of subjects: 1081

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1081
Study: 27492601

Group type: EXPERIMENTAL
Intervention: Intranasal insulin (40 IU)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 25005880

Group type: EXPERIMENTAL
Intervention: Target temperature of 33 °C
Number of subjects: 950

Group type: COMPARATOR
Intervention: Target temperature of 36 °C
Number of subjects: 950
Study: 22172922

Group type: EXPERIMENTAL
Intervention: Nurse-led cardiac rehabilitation
Number of subjects: 110

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 110
Study: 20335572

Group type: EXPERIMENTAL
Intervention: Aspirin plus nadroparin (2850 IU)
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Aspirin alone (80 mg)
Number of subjects: 364

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 364
Study: 17404460

Group type: EXPERIMENTAL
Intervention: JO plans with four apertures per beam angle (JO-4A)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 3D plans
Number of subjects: 10

Group type: COMPARATOR
Intervention: MLC plans
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Inverse IMRT plans
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: JO plans with varying apertures (2 to 7)
Number of subjects: 10
Study: 16050419

Group type: EXPERIMENTAL
Intervention: CCT measurement before GAT
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: CCT measurement after GAT
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: GAT measurement before pachymetry
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: GAT measurement after pachymetry
Number of subjects: 60
Study: 12131743

Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation in spinal cord injury patients
Number of subjects: 20

Group type: COMPARATOR
Intervention: Transcranial magnetic stimulation in control participants
Number of subjects: 20
Study: 9990745

Group type: EXPERIMENTAL
Intervention: 20% CO2-enriched air (UCS)
Number of subjects: 96

Group type: COMPARATOR
Intervention: 13% CO2-enriched air (UCS)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: High anxiety sensitivity
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Medium anxiety sensitivity
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Low anxiety sensitivity
Number of subjects: 96
Study: 7774735

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 (PGE2) gel (2 mg for primigravidae, 1 mg for parous)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 (PGE2) gel
Number of subjects: 260

Group type: COMPARATOR
Intervention: Forewater amniotomy
Number of subjects: 260
Study: 2274632

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg to 80 mg depending on response and side effects)
Number of subjects: 39
Study: 7195329

Group type: EXPERIMENTAL
Intervention: Supportive caregiving environment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonsupportive caregiving environment
Number of subjects: 0
Study: 29898788

Group type: EXPERIMENTAL
Intervention: Pixatimod (PG545) administered by intravenous (IV) infusion at a dose of up to 100 mg.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pixatimod in combination with PD-1 inhibitors (e.g., nivolumab).
Number of subjects: 0
Study: 27840257

Group type: EXPERIMENTAL
Intervention: eBV 0.2mL
Number of subjects: 20

Group type: COMPARATOR
Intervention: BV 0.2mL
Number of subjects: 20
Study: 23598957

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) for 2 months
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (no CPAP)
Number of subjects: 77
Study: 23715142

Group type: EXPERIMENTAL
Intervention: Lower eyelid blepharoplasty with periorbital fat mobilization and arcus marginalis redrape, routine lateral canthal support
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conservatively standard fat‐resection lower eyelid blepharoplasty, routine lateral canthal support
Number of subjects: 50
Study: 20863432

Group type: EXPERIMENTAL
Intervention: General anesthesia using isoflurane
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia using ropivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study: 19085781

Group type: EXPERIMENTAL
Intervention: Laser refractive surgery (OP group)
Number of subjects: 189
Study: 15883431

Group type: EXPERIMENTAL
Intervention: S-equol
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: R-equol
Number of subjects: 3
Study: 12556406

Group type: EXPERIMENTAL
Intervention: L-NMMA
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Phenylephrine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 10721926

Group type: EXPERIMENTAL
Intervention: Iron-folic acid (IFA) supplements
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (not specified what the control was)
Number of subjects: 90
Study: 9174874

Group type: EXPERIMENTAL
Intervention: Nilvadipine 8 mg
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Nilvadipine 16 mg
Number of subjects: 172

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172
Study: 14621818

Group type: EXPERIMENTAL
Intervention: University of Wisconsin (UW) solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: St. Thomas Hospital (ST) solution
Number of subjects: 0
Study: 4083859

Group type: EXPERIMENTAL
Intervention: Ampicillin with a lactobacillus preparation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ampicillin alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ampicillin followed 1 h later by the lactobacillus preparation
Number of subjects: 12
Study: 31592811

Group type: EXPERIMENTAL
Intervention: Intracorporeal ileocolic anastomosis (IIA)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Extracorporeal ileocolic anastomosis (EIA)
Number of subjects: 140
Study: 29915975

Group type: EXPERIMENTAL
Intervention: UVA1 therapy
Number of subjects: 68

Group type: COMPARATOR
Intervention: NB-UVB therapy
Number of subjects: 68
Study: 27596486

Group type: EXPERIMENTAL
Intervention: Diagnostic assessment with the EMBalance decision support system (DSS)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard practice (diagnostic assessment without the DSS)
Number of subjects: 200
Study: 25422027

Group type: EXPERIMENTAL
Intervention: Moderate-carbohydrate (40-45% of energy), increased-protein (25-30%) diet
Number of subjects: 111

Group type: COMPARATOR
Intervention: High-carbohydrate (55-60%), moderate-protein (15%) diet
Number of subjects: 111
Study: 22409295

Group type: EXPERIMENTAL
Intervention: Ofatumumab 500 mg
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Ofatumumab 1000 mg
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: O-CHOP (combined with ofatumumab)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 59
Study: 20813813

Group type: EXPERIMENTAL
Intervention: Acupuncture at both general acupuncture points and ah shi points
Number of subjects: 36

Group type: COMPARATOR
Intervention: Acupuncture at general acupuncture points only
Number of subjects: 36
Study: 18437442

Group type: EXPERIMENTAL
Intervention: Pioglitazone 30 mg daily for 6 months
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cold Pressor Test (CPT)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intracoronary glyceroltrinitrate
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Adenosine
Number of subjects: 50
Study: 15824254

Group type: COMPARATOR
Intervention: Choline‐containing compounds, phosphocreatine, myo‐inositol, total N‐acetyl‐aspartate (tNAA), and glutamate‐glutamine concentrations in cortical gray matter (CGM)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Myo‐inositol and total N‐acetyl‐aspartate (tNAA) concentrations in normal-appearing white matter (NAWM)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Expanded Disability Status Scale score
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Proton density lesion load
Number of subjects: 43
Study: 12869969

Group type: EXPERIMENTAL
Intervention: Gold sputter-coated titanium specimens fired in reduced argon atmosphere
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Gold sputter-coated titanium specimens fired in vacuum
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (conventional Au‐Pd‐In metal‐ceramic alloy)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Argon group without gold coating
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Argon group with gold coating
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Vacuum group without gold coating
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Vacuum group with gold coating
Number of subjects: 80
Study: 10507579

Group type: EXPERIMENTAL
Intervention: Intervention aimed at clinic leadership
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intervention aimed at all clinic physicians
Number of subjects: 0
Study: 8917033

Group type: EXPERIMENTAL
Intervention: Tracheal pressure triggering
Number of subjects: 14

Group type: COMPARATOR
Intervention: Flow‐by triggering
Number of subjects: 14

Group type: COMPARATOR
Intervention: Conventional pressure triggering
Number of subjects: 14
Study: 1847240

Group type: EXPERIMENTAL
Intervention: Induction combination chemotherapy (ICC)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Thoracic irradiation (after ICC)
Number of subjects: 48
Study: 6489410

Group type: EXPERIMENTAL
Intervention: Enprofylline 4 mg/kg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Theophylline 8 mg/kg
Number of subjects: 20
Study: 31316682

Group type: EXPERIMENTAL
Intervention: LIPUS combined with TENS therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Only TENS therapy
Number of subjects: 40